title: High expression of HMGA2 predicts poor survival in patients with clear cell renal cell carcinoma.
abstract: High-mobility group AT-hook 2 (HMGA2) is involved in a wide spectrum of biological processes and is upregulated in several tumors, but its role in renal carcinoma remains unclear. The aim of this study was to examine the expression of HMGA2 and its relationship to the overall survival (OS) of patients with non-metastatic clear cell renal cell carcinoma (ccRCC) following surgery. The expression of HMGA2 was evaluated retrospectively by immunohistochemistry (IHC) in 162 patients with ccRCC who underwent nephrectomy in 2003 and 2004. An IHC analysis revealed that HMGA2 was expressed in the nuclei of tumor cells in 146 (90.1%) patients with ccRCC. The level of HMGA2 was positively correlated with tumor size, lymph node metastasis, and Fuhrman Grade. A Kaplan-Meier analysis with log-rank test found that patients with high HMGA2 expression had a poor outcome and that patients with low HMGA2 expression had better survival. Cox regression analysis showed that HMGA2 expression could serve as an independent prognostic factor for ccRCC patients. The efficacy of the following prognostic models was improved when HMGA2 expression was added: tumor node metastasis stage, UCLA Integrated Scoring System, Mayo Clinic stage, size, grade, and necrosis score. In summary, this study showed that HMGA2 expression is an independent prognostic factor for OS in patients with ccRCC. HMGA2 was found to be a valuable biomarker for ccRCC progression.
authors.affiliation: Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University.
authors.forename: Ning
authors.initials: N
authors.lastname: Na
authors.affiliation: Department of Organ Transplant, The First Affiliated Hospital of Sun Yat-sen University.
authors.forename: Tujie
authors.initials: T
authors.lastname: Si
authors.affiliation: Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University.
authors.forename: Zhengyu
authors.initials: Z
authors.lastname: Huang
authors.affiliation: Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University.
authors.forename: Bin
authors.initials: B
authors.lastname: Miao
authors.affiliation: Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University.
authors.forename: Liangqing
authors.initials: L
authors.lastname: Hong
authors.affiliation: Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University.
authors.forename: Heng
authors.initials: H
authors.lastname: Li
authors.affiliation: Department of Organ Transplant, The First Affiliated Hospital of Sun Yat-sen University.
authors.forename: Jiang
authors.initials: J
authors.lastname: Qiu
authors.affiliation: Department of Urology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
authors.forename: Jianguang
authors.initials: J
authors.lastname: Qiu
keywords: high-mobility group protein A; prognosis; renal carcinoma